Ftse Mib
33.739,90
-0,08%
DAX
19.848,77
-0,34%
S&P 500
6.040,04
1,10%
NASDAQ
20.031,13
1,35%
Bitcoin
98.928,70
-0,38%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Y mAbs Therapeutics Inc (YMAB) Y mAbs Therapeutics Inc (YMAB) Notizie

Y mAbs Therapeutics Inc

YMAB
8,15
0,04 (0,49%)
24 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
23/12/202413:30GLOBEY-mAbs to Present at the 43rd Annual J.P. Morgan Healthcare..
07/12/202418:00GLOBEY-mAbs Presents SADA Platform Preclinical Data and Trial in..
27/11/202413:35GLOBEY-mAbs to Participate at Citi’s 2024 Global Healthcare..
14/11/202422:32EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
08/11/202413:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202412:55EDGAR2Form 8-K - Current report
08/11/202412:35GLOBEY-mAbs Reports Third Quarter 2024 Financial Results and..
04/11/202414:51EDGAR2Form 8-K - Current report
04/11/202413:35GLOBEY-mAbs and Nobelpharma Announce Exclusive License and..
25/10/202413:05GLOBEY-mAbs Announces Third Quarter 2024 Conference Call and..
01/10/202413:05GLOBEY-mAbs to Participate in Upcoming Investor Conferences in..
20/9/202422:16EDGAR2Form 8-K - Current report
20/9/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202402:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/9/202423:24EDGAR2Form 8-K - Current report
13/9/202422:19EDGAR2Form 144 - Report of proposed sale of securities
06/9/202413:30GLOBEY-mAbs Presents Neuroblastoma Research on Naxitamab and SADA..
03/9/202423:00EDGAR2Form 144 - Report of proposed sale of securities
03/9/202414:32GLOBEY-mAbs to Participate in Upcoming Investor Conferences in..
30/8/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/8/202423:12EDGAR2Form 144 - Report of proposed sale of securities
27/8/202423:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/8/202422:12EDGAR2Form 144 - Report of proposed sale of securities
12/8/202413:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/8/202412:50EDGAR2Form 8-K - Current report
12/8/202412:30GLOBEY-mAbs Reports Second Quarter 2024 Financial Results and..
07/8/202413:05GLOBEY-mAbs to Participate in Upcoming Investor Conferences in..
05/8/202422:05GLOBEY-mAbs Announces Second Quarter 2024 Conference Call and..
19/7/202422:15EDGAR2Form 8-K - Current report
01/7/202422:05GLOBEY-mAbs Appoints Seasoned Biopharma Executive Peter..
14/6/202403:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202403:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202422:05EDGAR2Form 8-K - Current report
12/6/202401:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202401:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/6/202422:59EDGAR2Form 144 - Report of proposed sale of securities
10/6/202422:44EDGAR2Form 144 - Report of proposed sale of securities
07/6/202413:05GLOBEY-mAbs Announces Preclinical GD2-SADA Data to be Presented..
05/6/202413:05GLOBEY-mAbs Deepens Radiopharmaceutical Leadership with..
01/6/202414:15GLOBEY-mAbs Announces Publication of Preclinical GD2-SADA Data at..
01/6/202414:05GLOBEY-mAbs Announces New Interim Analysis of Phase 2 Data for..
01/6/202403:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202400:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/5/202422:42EDGAR2Form 144 - Report of proposed sale of securities
07/5/202422:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202422:10EDGAR2Form 8-K - Current report
07/5/202422:05GLOBEY-mAbs Reports First Quarter 2024 Financial Results and..
26/4/202413:05GLOBEY-mAbs to Announce First Quarter 2024 Financial and..
25/4/202422:05GLOBEY-mAbs to Present at 2024 ASCO Annual Meeting
Apertura: 8,13 Min: 7,80 Max: 8,225
Chiusura: 8,11

La tua Cronologia

NASDAQ
YMAB
Y mAbs Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network